X-Linked Agammaglobulinaemia: Outcomes in the modern era.

Abstract

Colonel Ogden Bruton reported X-Linked Agammaglobulinaemia in 1952 and treated the child with replacement immunoglobulin therapy. Over 60years later, the treatment for XLA has largely remained unchanged. Replacement immunoglobulin lacks the isotypes IgA and IgM, leading to concerns that patients continue to experience recurrent sinopulmonary tract… (More)
DOI: 10.1016/j.clim.2017.07.008

Topics

2 Figures and Tables

Cite this paper

@article{Shillitoe2017XLinkedAO, title={X-Linked Agammaglobulinaemia: Outcomes in the modern era.}, author={Ben Shillitoe and Andrew Gennery}, journal={Clinical immunology}, year={2017}, volume={183}, pages={54-62} }